LY3143921 hydrate

TargetMol
Product Code: TAR-T9064
Supplier: TargetMol
CodeSizePrice
TAR-T9064-1mg1mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9064-5mg5mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9064-10mg10mg£185.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9064-25mg25mg£264.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9064-50mg50mg£364.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9064-100mg100mg£519.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
LY3143921 hydrate is an orally administered ATP-competitive?CDC7?inhibitor.
CAS:
1627696-53-0
Formula:
C16H14FN5O2
Molecular Weight:
327.319
Pathway:
Cell Cycle/Checkpoint
Purity:
0.9843
SMILES:
O.C[C@@]1(NC(=O)c2cc(ccc12)-c1cn[nH]c1)c1ncncc1F
Target:
CDK

References

Gallagher P F , Coyle V , Evans T , et al. A CRUK first-in-human phase I trial of a CDC7 Inhibitor, LY3143921 hydrate, in patients with advanced solid tumors.[J]. Journal of Clinical Oncology, 2019, 37(15_suppl):TPS3167-TPS3167.